Literature DB >> 18096140

Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis.

Jessica L Lynch1, Jeremy F Alley, Lori Wellman, Alvin J Beitz.   

Abstract

Multiple sclerosis patients typically experience increased pain that is relatively insensitive to opiate treatment. The mechanistic basis for this increased nociception is currently poorly understood. In the present study, we utilized the Theiler's murine encephalomyelitis virus (TMEV) model of MS to examine possible changes in spinal cord opioid receptor mRNA over the course of disease progression. TMEV infection led to significantly decreased mu, delta and kappa opioid receptor mRNA expression as analyzed by quantitative real-time PCR in both male and female mice at days 90, 150 and 180 post-infection (PI). Since opioid receptor mRNA expression decreased in TMEV mice, we examined whether opiate analgesia is also altered. TMEV infected female mice had significantly decreased opiate analgesia in thermal nociceptive tests beginning at day 90 PI, while TMEV-infected male mice did not display significantly decreased opiate analgesia until day 120 PI. The novel finding that opioid receptor expression is significantly decreased in the spinal cord of TMEV mice could explain the increased nociception and loss of opiate analgesia observed in both TMEV mice and multiple sclerosis patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18096140      PMCID: PMC2258219          DOI: 10.1016/j.brainres.2007.11.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  60 in total

Review 1.  Clinical pharmacology of opioids for pain.

Authors:  Charles E Inturrisi
Journal:  Clin J Pain       Date:  2002 Jul-Aug       Impact factor: 3.442

2.  Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine.

Authors:  Sigga Kalman; Anders Osterberg; Jan Sörensen; Jörgen Boivie; Ake Bertler
Journal:  Eur J Pain       Date:  2002       Impact factor: 3.931

3.  Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induced analgesia in rats.

Authors:  Nian-Lin Han; Fei Luo; Zhu-Ping Bian; Ji-Sheng Han
Journal:  Pain       Date:  2000-04       Impact factor: 6.961

4.  More severe neurologic deficits in SJL/J male than female mice following Theiler's virus-induced CNS demyelination.

Authors:  Jeremy Alley; Sergey Khasabov; Don Simone; Alvin Beitz; Moses Rodriguez; M Kariuki Njenga
Journal:  Exp Neurol       Date:  2003-03       Impact factor: 5.330

Review 5.  Sex differences in opioid analgesia: "from mouse to man".

Authors:  Rebecca M Craft
Journal:  Clin J Pain       Date:  2003 May-Jun       Impact factor: 3.442

6.  Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system.

Authors:  Gabriel Palacios; Asunción Muro; José Miguel Vela; Eduardo Molina-Holgado; Xavier Guitart; Sergio Ovalle; Daniel Zamanillo
Journal:  Brain Res       Date:  2003-01-24       Impact factor: 3.252

7.  Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.

Authors:  Shao-Rui Chen; Hui-Lin Pan
Journal:  Brain Res       Date:  2006-02-24       Impact factor: 3.252

8.  Pain in patients with multiple sclerosis: a population-based study.

Authors:  Kristina Bacher Svendsen; Troels Staehelin Jensen; Kim Overvad; Hans Jacob Hansen; Nils Koch-Henriksen; Flemming W Bach
Journal:  Arch Neurol       Date:  2003-08

9.  Angiotensin type 1 receptor immunoreactivity in the thoracic spinal cord.

Authors:  Zai Ahmad; Carol J Milligan; Julian F R Paton; Jim Deuchars
Journal:  Brain Res       Date:  2003-09-19       Impact factor: 3.252

10.  Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats.

Authors:  S Ballet; M Conrath; J Fischer; T Kaneko; M Hamon; F Cesselin
Journal:  Neuropeptides       Date:  2003-08       Impact factor: 3.286

View more
  12 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Deficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiation.

Authors:  Weiming Lai; Yingying Cai; Jinfeng Zhou; Shuai Chen; Chaoyan Qin; Cuixia Yang; Junling Liu; Xin Xie; Changsheng Du
Journal:  Cell Mol Immunol       Date:  2017-02-20       Impact factor: 11.530

Review 4.  Sex differences in kappa opioid pharmacology.

Authors:  Khampaseuth Rasakham; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2010-10-14       Impact factor: 5.037

5.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014

6.  Social disruption alters pain and cognition in an animal model of multiple sclerosis.

Authors:  H R Linsenbardt; J L Cook; E E Young; E G Vichaya; C R Young; N M Reusser; R Storts; C J Welsh; M W Meagher
Journal:  J Neuroimmunol       Date:  2015-09-12       Impact factor: 3.478

Review 7.  Opioids Resistance in Chronic Pain Management.

Authors:  Luigi A Morrone; Damiana Scuteri; Laura Rombolà; Hirokazu Mizoguchi; Giacinto Bagetta
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

8.  Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.

Authors:  Raphaël Weibel; David Reiss; Laurie Karchewski; Olivier Gardon; Audrey Matifas; Dominique Filliol; Jérôme A J Becker; John N Wood; Brigitte L Kieffer; Claire Gaveriaux-Ruff
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

9.  Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus.

Authors:  Elizabeth J Rahn; Tommaso Iannitti; Renee R Donahue; Bradley K Taylor
Journal:  Biol Sex Differ       Date:  2014-02-28       Impact factor: 5.027

10.  Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.

Authors:  Changsheng Du; Yanhui Duan; Wei Wei; Yingying Cai; Hui Chai; Jie Lv; Xiling Du; Jian Zhu; Xin Xie
Journal:  Nat Commun       Date:  2016-04-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.